BTMD
biote Corp
NASDAQ: BTMD · HEALTHCARE · MEDICAL CARE FACILITIES
$2.22
+0.00% today
Updated 2026-04-30
Market cap
$73.07M
P/E ratio
3.08
P/S ratio
0.38x
EPS (TTM)
$0.74
Dividend yield
—
52W range
$1 – $5
Volume
0.3M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
3.3
Growth
D6.5
Quality
B6.5
Profitability
B8.3
Valuation
A5/9
Piotroski F-Score
Moderate
1.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$2.97
+33.96%
12-Month target
$1.15
-48.20%
Intrinsic (DCF)
$15.78
Margin of safety
+86.57%
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $6.49M — positive
+ 86.57% below intrinsic value
+ Debt/equity -1.46x — low leverage
Risks
- Altman Z 1.54 — distress zone
- Revenue declining -6.90% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $164.96M | $185.36M | $197.19M | $192.22M | $192.22M |
| Net income | $-969000.00 | $3.32M | $3.16M | $27.05M | $1.95M |
| EPS | — | — | — | — | $0.74 |
| Free cash flow | $-10.99M | $24.17M | $38.81M | $30.18M | $6.49M |
| Profit margin | -0.59% | 1.79% | 1.60% | 14.07% | 14.10% |
Peer comparison
Smart narrative
biote Corp trades at $2.22. representing a P/E of 3.08x trailing earnings. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.54, it sits in the distress. TTM revenue stands at $192.22M. with profit margins at 14.10%. Our DCF model estimates intrinsic value at $15.78.
Frequently asked questions
What is biote Corp's stock price?
biote Corp (BTMD) trades at $2.22.
Is biote Corp overvalued?
Smart Value Score 37/100 (Grade D, Sell). DCF value $15.78.
What is the price target of biote Corp (BTMD)?
The analyst target price is $2.97, representing +34.0% upside from the current price of $2.22.
What is the intrinsic value of biote Corp (BTMD)?
Based on our DCF model, intrinsic value is $15.78, a +86.6% margin of safety versus $2.22.
What is biote Corp's revenue?
TTM revenue is $192.22M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
1.54 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.38x
ROE—
Beta1.29
50D MA$1.81
200D MA$2.67
Shares out0.03B
Float0.02B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—